New guideline in the US: No more dental amalgam for patients with neurological diseases and women who wish to have children
The US Food and Drug Administration (FDA) has issued a new guideline on the use of dental amalgam. The FDA recommends that mercury-containg fillings should no longer be used for patients with neurological diseases such as multiple sclerosis, Alzheimer’s and Parkinson’s, as well as patients
September 29, 2020
